|
1
|
American Thoracic Society. Idiopathic
pulmonary fibrosis: diagnosis and treatment. International
consensus statement American Thoracic Society (ATS), and the
European Respiratory Society (ERS). Am J Respir Crit Care Med.
161:646–664. 2000. View Article : Google Scholar
|
|
2
|
Noble PW and Homer RJ: Back to the future:
historical perspective on the pathogenesis of idiopathic pulmonary
fibrosis. Am J Respir Cell Mol Biol. 33:113–120. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noble PW and Homer RJ: Idiopathic
pulmonary fibrosis: new insights into pathogenesis. Clin Chest Med.
25:749–758. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ding Q, Luckhardt T, Hecker L, et al: New
insights into the pathogenesis and treatment of idiopathic
pulmonary fibrosis. Drugs. 71:981–1001. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
ENCODE Project Consortium. Birney E,
Stamatoyannopoulos JA, Dutta A, et al: Identification and analysis
of functional elements in 1% of the human genome by the ENCODE
pilot project. Nature. 447:799–816. 2007.
|
|
6
|
Guttman M, Amit I, Garber M, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs inmammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagano T and Fraser P: Emerging
similarities in epigenetic gene silencing by long noncoding RNAs.
Mamm Genome. 20:557–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim A, Zhao H, Ifrim I and Dean A:
Beta-globin intergenic transcription and histone acetylation
dependent on an enhancer. Mol Cell Biol. 27:2980–2986. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee JT: Lessons from X-chromosome
inactivation: long ncRNA as guides and tethers to the epigenome.
Genes Dev. 23:1831–1842. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rinn JL, Kertesz M, Wang JK, et al:
Functional demarcation of active and silent chromatin domains in
human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krangel MS: T cell development: better
living through chromatin. Nat Immunol. 8:687–694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perez DS, Hoage TR, Pritchett JR, et al:
Long, abundantly expressed non-coding transcripts are altered in
cancer. Hum Mol Genet. 17:642–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kanehisa M, Goto S, Furumichi M, Tanabe M
and Hirakawa M: KEGG for representation and analysis of molecular
networks involving diseases and drugs. Nucleic Acids Res.
38:D355–D360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar
|
|
15
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar
|
|
17
|
Hindorff LA, Sethupathy P, Junkins HA,
Ramos EM, Mehta JP, Collins FS and Manolio TA: Potential etiologic
and functional implications of genome-wide association loci for
human diseases and traits. Proc Natl Acad Sci USA. 106:9362–9367.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin R, Maeda S, Liu C, Karin M and
Edgington TS: A large noncoding RNA is a marker for murine
hepatocelluar carcinomas and a spectrum of human carcinomas.
Oncogene. 26:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qureshi IA, Mattick JS and Mehler MF: Long
non-coding RNAs in nervous system function and disease. Brain Res.
1338:20–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tufarelli C, Stanley JA, Garrick D, Sharpe
JA, Ayyub H, Wood WG and Higgs DR: Transcription of antisense RNA
leading to gene silencing and methylation as a novel cause of human
genetic disease. Nat Genet. 34:157–165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sui W, Yan Q, Li H, Liu J, Chen J, Li L
and Dai Y: Genome-wide analysis of long noncoding RNA expression in
peripheral blood mononuclear cells of uremia patients. J Nephrol.
Oct 24–2012.(Epub ahead of print).
|
|
23
|
Steck E, Boeuf S, Gabler J, Werth N,
Schnatzer P, Diederichs S and Richter W: Regulation of H19 and its
encoded microRNA-675 in osteoarthritis and under anabolic and
catabolic in vitro conditions. J Mol Med (Berl). 90:1185–1195.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tran VG, Court F, Duputié A, Antoine E, et
al: H19 antisense RNA can up-regulate Igf2 transcription by
activation of a novel promoter in mouse myoblasts. PLoS One.
7:e379232012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maida Y, Yasukawa M, Furuuchi M, et al: An
RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.
Nature. 461:230–235. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calado RT and Young NS: Telomere
maintenance and human bone marrow failure. Blood. 111:4446–4455.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weinrich SL, Pruzan R, Ma L, et al:
Reconstitution of human telomerase with the template RNA component
hTR and the catalytic protein subunit hTRT. Nat Genet. 17:498–502.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Q, Kim NK and Feigon J: Architecture
of human telomerase RNA. Proc Natl Acad Sci USA. 108:20325–20332.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cong Y and Shay JW: Actions of human
telomerase beyond telomeres. Cell Res. 18:725–732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zvereva MI, Shcherbakova DM and Dontsova
OA: Telomerase: structure, functions, and activity regulation.
Biochemistry (Mosc). 75:1563–1583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Calado RT and Young NS: Telomere diseases.
N Engl J Med. 361:2353–2365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aalbers AM, Kajigaya S, van den
Heuvel-Eibrink MM, van der Velden VH, Calado RT and Young NS: Human
telomere disease due to disruption of the CCAAT box of the TERC
promoter. Blood. 119:3060–3063. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuan SX, Yang F, Yang Y, et al: Long
noncoding RNA associated with microvascular invasion in
hepatocellular carcinoma promotes angiogenesis and serves as a
predictor for hepatocellular carcinoma patients' poor
recurrence-free survival after hepatectomy. Hepatology.
56:2231–2241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu Z, Gao X, He Y, et al: An
insertion/deletion polymorphism within RERT-lncRNA modulates
hepatocellular carcinoma risk. Cancer Res. 72:6163–6172. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dharap A, Nakka VP and Vemuganti R: Effect
of focal ischemia on long noncoding RNAs. Stroke. 43:2800–2802.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ziats MN and Rennert OM: Aberrant
epxpression of long noncoding RNAs in autistic brain. J Mol
Neurosci. 49:589–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dinger ME, Pang KC, Mercer TR and Mattick
JS: Differentiating protein-coding and noncoding RNA: challenges
and ambiguities. PLoS Comput Biol. 4:e10001762008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ulveling D, Francastel C and Hube F: When
one is better than two: RNA with dual functions. Biochimie.
93:633–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanaoka M, Ito M, Droma Y, Ushiki A,
Kitaguchi Y, Yasuo M and Kubo K: Comparison of gene expression
profiling between lung fibrotic and emphysematous tissues sampled
from patients with combined pulmonary fibrosis and emphysema.
Fibrogenesis Tissue Repair. 5:172012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Konishi K, Gibson KF, Lindell KO, et al:
Gene expression profiles of acute exacerbations of idiopathic
pulmonary fibrosis. Am J Respir Crit Care Med. 180:167–175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xie T, Liang J, Guo R, Liu N, Noble PW and
Jiang D: Comprehensive microRNA analysis in bleomycin-induced
pulmonary fibrosis identifies multiple sites of molecular
regulation. Physiol Genomics. 43:479–487. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kulkarni AA, Thatcher TH, Olsen KC,
Maggirwar SB, Phipps RP and Sime PJ: PPAR-γ ligands repress
TGFβ-induced myofibroblast differentiation by targeting the
PI3K/Akt pathway: implications for therapy of fibrosis. PLoS One.
6:e159092011.
|
|
43
|
Ferguson HE, Kulkarni A, Lehmann GM, et
al: Electrophilic peroxisome proliferator-activated receptor-γ
ligands have potent antifibrotic effects in human lung fibroblasts.
Am J Respir Cell Mol Biol. 41:722–730. 2009.
|
